Breast Cancer | Quick Facts Early detection is your best protection: A woman's chance of detecting breast cancer in her life is 1 in 8.
Top two risks: 1. Being female. + 2. Getting older.
Mammography is still the gold standard to detect breast cancer. With early detection, the five year survival rate from breast cancer is almost 100%.
More than 75% of women with breast cancer have no family history of the disease and less then 10% have a known gene mutation that increases risk.
Breast Cancer Mortality Rates are Declining.
This year, we will lose more than 522,000 women worldwide to breast cancer. More than 1,400 Women will die each day from breast cancer. (GloboCan, 2012)
Racial Disparity: Black women are more likely to die of breast cancer than white women. Breast cancer mortality is 40% higher among black women compared with white women.
Metastatic Breast Cancer Metastatic breast cancer is cancer that has spread from the breast to the bones, lungs, or other distant parts of the body. 90% of breast cancer deaths are as a result of metastatic disease.
In 2018, about 266,120 women will be diagnosed with invasive breast cancer, as will 2,550 men in the United States. About 63,960 new cases of carcinoma in situ (CIS) will be diagnosed. In the US in 2018, about 40,920 women and 480 men will die from breast cancer. There are approximately 150,000 women living in the United States today with metastatic breast cancer.
While statistics are not collected for metastatic recurrences which comprise the larger portion of metastatic breast cancer cases, it is estimated that 20 to 30% of women with breast cancer recur with metastatic disease. 6 to 10% are diagnosed initially with metastatic breast cancer. The average age of breast cancer diagnosis is 62; the average age of death from breast cancer is 68. (ACS/NBCC 2018)
“You are braver than you believe, stronger than you seem, smarter than you think, and twice as beautiful as you’d ever imagined.”
WE STAND WITH THE National Breast Cancer Coalition (NBCC) AND SUPPORT: HR 6114 | Metastatic Breast Cancer Access to Care Act
HR 6114 would waive the 24-month waiting period for Medicare eligibility and the 5-month waiting period of Social Security Disability Insurance benefits for individuals with metastatic breast cancer.